News

Anpario plc (LON:ANP) has announced that it will be increasing its periodic dividend on the 25th of July to £0.08, which will be 6.7% higher than last year's comparable payment amount of £0.075. This ...
Anpario plc (LON:ANP – Get Free Report) insider Marc Wilson bought 3,778 shares of the stock in a transaction that occurred on Tuesday, April 1st. The shares were purchased at an average cost of GBX ...
Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Herein, a new rG4 located in the 5′UTR of the MAOB mRNA was ...
Here we report the use of C5-propynyl-dU,dC-phosphorothioate antisense oligonucleotides to inhibit IGF-I receptor expression in keratinocytes. We identified several inhibitory antisense ...
Japan's Ono Pharmaceutical bought an antisense oligonucleotide from Ionis Pharmaceuticals. Plus more. 1. 'I don't feel we lost momentum': Takeda’s oncology execs sharpen focus after ...
One of the most effective ways to achieve this is by leading by example. Leadership is not about wielding authority or directing others; it’s about inspiring and empowering those around you.
Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense oligonucleotide for a rare type of blood cancer. The RNA-targeted ...
Sveltekit starter project created with sveltekit, typescript, tailwindcss, postcss, husky, and storybook. The project has the structure set up for the scaleable web application.
Antisense Oligonucleotides Market forecast to 2035 highlights size, emerging trends, key applications, and growth drivers shaping the future of genetic therapies.